Q2 2021

Welcome to the 2021 Q2 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

While the last eighteen months have seen all industries demonstrating resilience and versatility in a period defined by adversity, few have matched the exceptional work of the global healthcare and pharmaceutical industries. These impressive feats are by no means limited to successful vaccine programme rollouts or treatment of Covid-19 cases – as individuals have become more aware of the importance of caring for our general physical and mental wellbeing during the pandemic, organisations across the industry have seen demand for their products and services soar.

That is certainly the case for the companies included in this quarter’s edition of GHP, including our cover company, BioMin Technologies, a leading researcher into dental sensitivity and developer of sensitivity relief and prevention products. We find out how this London-based start-up has grown since 2015 and plans to build on the momentum generated in online sales during the pandemic to see further growth that facilitates exciting advanced research into dental sensitivities.

Join us as we explore many of the other success stories to come out of this vibrant and valued industry over the past few months. Until the next issue of GHP, we wish you all the best for the months ahead.

Q4 2020

Welcome to the Q4 edition of Global Health & Pharma Magazine, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

These past twelve months have certainly been a turbulent time, especially for those working within healthcare and pharmaceutical industry. Whilst some have had to shut their doors due to safety concerns, others have found great success.

For example, Fortress Diagnostics who develops, manufactures and supports an extensive portfolio of clinical diagnostic tests had to alter the way in which they shipped orders to ensure all customer needs were met. The result? The number of partners increased, plus their quality is much higher than it was previously.

This success story is just one of the many featured within the pages of this packed and insightful issue of Global Health & Pharma. For now, we hope that you stay safe and have a Merry Christmas and a wonderful New Year, and we look forward to welcoming you back in 2021.

Q3 2020

Welcome to the Q3 issue of Global Health & Pharma Magazine – your source for all of the latest news and features from across the healthcare and pharmaceutical landscape.

It is safe to say these past few months have tested the capabilities of many, especially those working in healthcare and pharmaceutical industries. For many companies operating within such a dynamic and ever-changing industries such as healthcare, the pandemic has created a number of opportunities that they could have never predicted.

In this issue, we take a closer look at the firms who have been fortunate to expand their business during these unprecedented times. From a light sensor designed for seniors dealing with rehabilitation and readjusting to normal life during the COVID-19 pandemic, to a dental practice which is increasing its brand awareness expanding the business whilst diluting the excellence of its existing services. We cover a selection of businesses who have done all they can to remain operational during lockdown and how they are coping post lockdown too.

For now, the team here at Global Health & Pharma hope you are doing well and staying safe, and look forward to hearing from you soon.

Q2 2020

Welcome to the Q2 issue of Global Health & Pharma Magazine – your source for the latest news and features from across the healthcare and pharmaceutical industries.  

It’s been a strange time, though (maybe it’s the eternal optimist in me) it looks like things are changing. Tentatively, slowly, we’re seeing a shift towards ‘normal’, whatever form ‘normal’ might take going forwards. Where the world has seemed to slow to a snail’s pace, the healthcare and pharmaceutical industries have moved forward relentlessly. This dichotomy has never been more obvious than in the last few months. Healthcare never stops. It can’t – it’s fundamental. It’s a cornerstone to society. The entire industry, and its supplementary fields, keep the world moving. We’ve seen that now with perfect clarity.

With this issue, we want to showcase a selection of the businesses that don’t stop. That keep moving, onwards, further, higher.

In the meantime, I hope you all have a wonderful few months ahead. Stay safe and well.

Q1 2020

Welcome to the Q1 issue of Global Health & Pharma Magazine – your source for the latest news and features from across the healthcare and pharmaceutical industries.

I don’t think any of us expected to be writing automatic replies that spoke of “pandemics”, and its profound impact on day to day affairs. Yet, here we are.

It’s all a bit surreal. Anxiety and unease are high, and the best method for coping right now is to adopt the rather timeless approach of “keeping calm and carrying on”.

Naturally, while there are mentions of COVID-19 and the Coronavirus in this issue, we’ve tried to keep it to a minimum. After all, while it’s a good idea to stay informed and in the know, there’s such a thing as too much information. It’s OK – in fact, highly encouraged – to take a break. Do something fun. Something you enjoy. Take a moment for yourself.

Whether you’re self-isolating at home, on the frontlines in hospitals and surgeries across the world, or making sure your nations carry on, GHP News hopes you all stay safe and well. This too shall pass.